386 related articles for article (PubMed ID: 33193296)
21. Rationally Designed Influenza Virus Vaccines That Are Antigenically Stable during Growth in Eggs.
Harding AT; Heaton BE; Dumm RE; Heaton NS
mBio; 2017 Jun; 8(3):. PubMed ID: 28588131
[TBL] [Abstract][Full Text] [Related]
22. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
[TBL] [Abstract][Full Text] [Related]
23. Differential Modulation of Innate Immune Responses in Human Primary Cells by Influenza A Viruses Carrying Human or Avian Nonstructural Protein 1.
Monteagudo PL; Muñoz-Moreno R; Fribourg M; Potla U; Mena I; Marjanovic N; Hartmann BM; Sealfon SC; García-Sastre A; Ramos I; Fernández-Sesma A
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597767
[TBL] [Abstract][Full Text] [Related]
24. Swine influenza A virus: challenges and novel vaccine strategies.
Petro-Turnquist E; Pekarek MJ; Weaver EA
Front Cell Infect Microbiol; 2024; 14():1336013. PubMed ID: 38633745
[TBL] [Abstract][Full Text] [Related]
25. Inactivated influenza vaccine adjuvanted with bacterium-like particles induce systemic and mucosal influenza A virus specific T-cell and B-cell responses after nasal administration in a TLR2 dependent fashion.
Keijzer C; Haijema BJ; Meijerhof T; Voorn P; de Haan A; Leenhouts K; van Roosmalen ML; van Eden W; Broere F
Vaccine; 2014 May; 32(24):2904-10. PubMed ID: 24598720
[TBL] [Abstract][Full Text] [Related]
26. Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans.
De Santo C; Salio M; Masri SH; Lee LY; Dong T; Speak AO; Porubsky S; Booth S; Veerapen N; Besra GS; Gröne HJ; Platt FM; Zambon M; Cerundolo V
J Clin Invest; 2008 Dec; 118(12):4036-48. PubMed ID: 19033672
[TBL] [Abstract][Full Text] [Related]
27. Immune Responses to Avian Influenza Viruses.
Koutsakos M; Kedzierska K; Subbarao K
J Immunol; 2019 Jan; 202(2):382-391. PubMed ID: 30617120
[TBL] [Abstract][Full Text] [Related]
28. Adjuvanted influenza vaccines.
Tregoning JS; Russell RF; Kinnear E
Hum Vaccin Immunother; 2018 Mar; 14(3):550-564. PubMed ID: 29232151
[TBL] [Abstract][Full Text] [Related]
29. Flagellin-expressing virus-like particles exhibit adjuvant effects on promoting IgG isotype-switched long-lasting antibody induction and protection of influenza vaccines in CD4-deficient mice.
Ko EJ; Lee Y; Lee YT; Jung YJ; Ngo VL; Kim MC; Kim KH; Wang BZ; Gewirtz AT; Kang SM
Vaccine; 2019 Jun; 37(26):3426-3434. PubMed ID: 31101421
[TBL] [Abstract][Full Text] [Related]
30. Memory T Cell Dynamics in the Lung during Influenza Virus Infection.
Pizzolla A; Wakim LM
J Immunol; 2019 Jan; 202(2):374-381. PubMed ID: 30617119
[TBL] [Abstract][Full Text] [Related]
31. Immunological responses to influenza vaccination: lessons for improving vaccine efficacy.
Wang TT; Bournazos S; Ravetch JV
Curr Opin Immunol; 2018 Aug; 53():124-129. PubMed ID: 29753885
[TBL] [Abstract][Full Text] [Related]
32. The Role of Innate Leukocytes during Influenza Virus Infection.
Lamichhane PP; Samarasinghe AE
J Immunol Res; 2019; 2019():8028725. PubMed ID: 31612153
[TBL] [Abstract][Full Text] [Related]
33. A Novel Vaccination Strategy Mediating the Induction of Lung-Resident Memory CD8 T Cells Confers Heterosubtypic Immunity against Future Pandemic Influenza Virus.
Lee YN; Lee YT; Kim MC; Gewirtz AT; Kang SM
J Immunol; 2016 Mar; 196(6):2637-45. PubMed ID: 26864033
[TBL] [Abstract][Full Text] [Related]
34. Co-immunization with tandem repeat heterologous M2 extracellular proteins overcomes strain-specific protection of split vaccine against influenza A virus.
Lee YN; Kim MC; Lee YT; Kim YJ; Lee J; Kim C; Ha SH; Kang SM
Antiviral Res; 2015 Oct; 122():82-90. PubMed ID: 26248203
[TBL] [Abstract][Full Text] [Related]
35. Why Are CD8 T Cell Epitopes of Human Influenza A Virus Conserved?
Li ZT; Zarnitsyna VI; Lowen AC; Weissman D; Koelle K; Kohlmeier JE; Antia R
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626684
[TBL] [Abstract][Full Text] [Related]
36. A virus-like particle vaccine candidate for influenza A virus based on multiple conserved antigens presented on hepatitis B tandem core particles.
Ramirez A; Morris S; Maucourant S; D'Ascanio I; Crescente V; Lu IN; Farinelle S; Muller CP; Whelan M; Rosenberg W
Vaccine; 2018 Feb; 36(6):873-880. PubMed ID: 29306508
[TBL] [Abstract][Full Text] [Related]
37. Human influenza viruses and CD8(+) T cell responses.
Grant EJ; Quiñones-Parra SM; Clemens EB; Kedzierska K
Curr Opin Virol; 2016 Feb; 16():132-142. PubMed ID: 26974887
[TBL] [Abstract][Full Text] [Related]
38. Understanding immunity to influenza: implications for future vaccine development.
Tripp RA
Expert Rev Vaccines; 2023; 22(1):871-875. PubMed ID: 37794732
[TBL] [Abstract][Full Text] [Related]
39. Immunity to influenza: the challenges of protecting an aging population.
Katz JM; Plowden J; Renshaw-Hoelscher M; Lu X; Tumpey TM; Sambhara S
Immunol Res; 2004; 29(1-3):113-24. PubMed ID: 15181275
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-Based Attenuation of Influenza Virus across Susceptible Hosts.
Waring BM; Sjaastad LE; Fiege JK; Fay EJ; Reyes I; Moriarity B; Langlois RA
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
